Haşmet Hanağasi

8PUBLICATIONS
104CO-AUTHORS
Autonomic nervous systemNeurology and neuromuscular diseasesPharmacogenomicsMedical biochemistry - proteins and peptides (incl. medical proteomics)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Rethinking Alzheimer's Disease Therapy: From Amyloid-Centric Approaches to Multi-Target Phytochemical Strategies.

|May 27, 2026
The APOA1-SNCA Axis as a Molecular Bridge Between CKD and Parkinson's Disease: A Systems Biology Model of Kidney-to-Brain Propagation via Exosomal Pathways.

|Apr 15, 2026
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

|Aug 14, 2025
Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives.

Emre Aktaş, Haşmet Ayhan Hanağası, Nehir Özdemir Özgentürk

|Aug 16, 2024
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality and disrupt mitochondrial function.

Francesca Magrinelli, Christelle Tesson, Plamena R Angelova

|Mar 24, 2022
Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment.

Betul Sumbul-Sekerci, Hasmet A Hanagasi, Basar Bilgic

Pageof 2

Frequent Collaborators

6 joint publications

Başar Bilgiç

3 joint publications

Alexis Brice

3 joint publications

Bedia Samanci

3 joint publications

Andrey Y Abramov